Showing results (891-900 of 1,095) with videos related to

Sort By:
Pageof 110
Lancet (London, England)|February 7, 2002
Pulmonary extravascular fluid accumulation in recreational climbers: a prospective studyGeorge Cremona, Roberto Asnaghi, Paolo Baderna, et al.
Clinical Lung Cancer|November 21, 2017
Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung CancerElisa Gobbini, Sara Pilotto, Giulia Pasello, et al.
Scientific Reports|June 22, 2022
South American precipitation dipole forced by interhemispheric temperature gradientMarília C Campos, Cristiano M Chiessi, Valdir F Novello, et al.
Therapeutic Advances in Medical Oncology|August 1, 2020
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial)Francesco Gelsomino, Giuseppe Lamberti, Marcello Tiseo, et al.
The Clinical Respiratory Journal|May 4, 2017
Final data of an Italian multicentric survey about counseling for smoking cessation in patients with diagnosis of a respiratory diseaseEnrica Capelletto, Simonetta Grazia Rapetti, Sara Demichelis, et al.
Journal of Clinical Medicine|May 13, 2026
Psychological Burden in Uncontrolled Hypertension: Findings from the ERIDANO Multicenter StudyFrancesca Novello, Fabrizio Vallelonga, Samuel Agostino, et al.
Critical Reviews in Oncology/Hematology|November 21, 2021
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patientsUmberto Malapelle, Sara Pilotto, Maria Lucia Reale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2020
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancerD Planchard, N Reinmuth, S Orlov, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2019
EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic diseaseAntonin Levy, Lizza E L Hendriks, Thierry Berghmans, et al.
Lung Cancer (Amsterdam, Netherlands)|April 9, 2024
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based databaseUmberto Malapelle, Francesco Passiglia, Francesco Pepe, et al.
Pageof 110